New treatments and research boost lung cancer survival rates in Canada

New treatments and research are improving survival rates for lung cancer patients in Canada, according to the Lung Health Foundation. Advances in precision medicine and targeted therapies have led to a significant increase in long-term survival rates, now over 15%. Patients like Steve Blake and Katie Hulan exemplify this progress, having outlived their initial diagnoses. The Lung Health Foundation has also launched a patient input system to influence drug reviews, enhancing treatment options for Canadians facing lung cancer. Mobile lung cancer screening programs are being explored to improve early detection, especially in underserved communities. The Lung Health Foundation emphasizes the need for government support to implement these initiatives effectively.